Genenta Science Statistics
Total Valuation
Genenta Science has a market cap or net worth of $14.82 million. The enterprise value is -$9.31 million.
Important Dates
The last earnings date was Tuesday, March 24, 2026.
| Earnings Date | Mar 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genenta Science has 23.59 million shares outstanding. The number of shares has increased by 7.86% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 23.59M |
| Shares Change (YoY) | +7.86% |
| Shares Change (QoQ) | +10.04% |
| Owned by Insiders (%) | 23.31% |
| Owned by Institutions (%) | 7.69% |
| Float | 13.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.16, with a Debt / Equity ratio of 0.35.
| Current Ratio | 14.16 |
| Quick Ratio | 13.90 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.03% and return on invested capital (ROIC) is -19.68%.
| Return on Equity (ROE) | -38.03% |
| Return on Assets (ROA) | -17.67% |
| Return on Invested Capital (ROIC) | -19.68% |
| Return on Capital Employed (ROCE) | -22.18% |
| Weighted Average Cost of Capital (WACC) | 5.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$851,868 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.94% in the last 52 weeks. The beta is 0.73, so Genenta Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -84.94% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 1.90 |
| Relative Strength Index (RSI) | 41.64 |
| Average Volume (20 Days) | 50,451 |
Short Selling Information
The latest short interest is 13,319, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 13,319 |
| Short Previous Month | 62,619 |
| Short % of Shares Out | 0.06% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.75M |
| Pretax Income | -7.67M |
| Net Income | -7.67M |
| EBITDA | -7.72M |
| EBIT | -7.75M |
| Earnings Per Share (EPS) | -$0.39 |
Full Income StatementBalance Sheet
The company has $33.05 million in cash and $8.93 million in debt, with a net cash position of $24.12 million or $1.02 per share.
| Cash & Cash Equivalents | 33.05M |
| Total Debt | 8.93M |
| Net Cash | 24.12M |
| Net Cash Per Share | $1.02 |
| Equity (Book Value) | 25.64M |
| Book Value Per Share | 1.09 |
| Working Capital | 32.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.06 million and capital expenditures -$8,953, giving a free cash flow of -$7.99 million.
| Operating Cash Flow | -8.06M |
| Capital Expenditures | -8,953 |
| Depreciation & Amortization | 32,638 |
| Net Borrowing | 8.72M |
| Free Cash Flow | -7.99M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
